renal cell carcinoma
Telix Seeking FDA Approval for Kidney Cancer Radiopharmaceutical Imaging Agent
The firm's biologics license application for TLX250-CDx was granted priority review and a decision is expected in August.
Merck's Welireg Approved in Europe for Von Hippel-Lindau-Associated Cancers
The European Commission granted approval for von Hippel-Lindau-associated renal cell carcinoma, CNS hemangioblastomas, or pancreatic neuroendocrine tumors.
Inceptor Bio Licenses Solid Tumor CAR T-Cell Therapy to Grit Bio in China
The firms are developing the autologous CAR T-cell therapy IB-T101 as a treatment for clear cell renal cell carcinoma.
Allarity Therapeutics Facing Potential Legal Action for Violation of SEC Laws
The SEC warned of enforcement action regarding Allarity's disclosures about FDA interactions seeking approval for dovitinib and its companion diagnostic.
Merck, Moderna Personalized Neoantigen Vaccine, Keytruda Combo Still Benefiting Melanoma Patients
Premium
After three years of follow-up, mRNA-4157 plus Keytruda led to a 49 percent reduction in the risk of disease recurrence or death versus Keytruda alone.